Invention Grant
- Patent Title: Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
- Patent Title (中): 含氮化合物及其药物组合物用于治疗房颤
-
Application No.: US13388442Application Date: 2010-08-20
-
Publication No.: US08822453B2Publication Date: 2014-09-02
- Inventor: Shuuji Matsumura , Hokuto Yamabe , Naohiro Isono , Noriaki Takemura , Takashi Oshiyama , Tsuyoshi Nagase , Masataka Ueda , Kuninori Tai
- Applicant: Shuuji Matsumura , Hokuto Yamabe , Naohiro Isono , Noriaki Takemura , Takashi Oshiyama , Tsuyoshi Nagase , Masataka Ueda , Kuninori Tai
- Applicant Address: JP Tokyo
- Assignee: Otsuka Pharmaceutical Co., Ltd.
- Current Assignee: Otsuka Pharmaceutical Co., Ltd.
- Current Assignee Address: JP Tokyo
- Agency: Sughrue Mion, PLLC
- International Application: PCT/JP2010/064545 WO 20100820
- International Announcement: WO2011/021726 WO 20110224
- Main IPC: C07D243/12
- IPC: C07D243/12 ; C07D409/12 ; C07D495/04 ; A61K31/551 ; A61K31/4985 ; A61P9/06 ; C07D401/14 ; C07D471/04 ; C07D403/12 ; C07D403/14 ; C07D401/12

Abstract:
The present invention provides a novel diazepine compound that blocks the IKur current or the Kv1.5 channel potently and more selectively than other K+ channels. The present invention relates to a diazepine compound represented by General Formula (1) or a salt thereof, wherein R1, R2, R3, and R4 are each independently hydrogen, lower alkyl, cyclo lower alkyl or lower alkoxy lower alkyl; R2 and R3 may be linked to form lower alkylene; A1 is lower alkylene optionally substituted with one or more substituents selected from the group consisting of hydroxyl and oxo; Y1 and Y2 are each independently —N═ or —CH═; and R5 is group represented by wherein R6 and R7 are each independently hydrogen or organic group; R6 and R7 may be linked to form a ring together with the neighboring group —XA—N—XB—; XA and XB are each independently a bond, lower alkylene, etc.
Public/Granted literature
Information query